A Cohort Study: to Assess the Value of Cardiovascular Imaging in Pediatric Myocarditis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Myocarditis
- Sponsor
- West China Second University Hospital
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Adverse cardiovascular events
- Status
- Enrolling By Invitation
- Last Updated
- last year
Overview
Brief Summary
This study aims to utilize cardiac magnetic resonance (CMR) to assist in the clinical diagnosis, conduct consecutive assessments for myocardial tissue in pediatrics with myocarditis, and explore effective predictive factors for adverse outcomes in pediatric myocarditis.
Participants will undergo baseline collection, laboratory tests, echocardiography, and CMR. All the consecutive data will be used to analyze the association with the diagnosis and prognosis of pediatric myocarditis.
Investigators
Ling-Yi Wen
Principal Investigator
West China Second University Hospital
Eligibility Criteria
Inclusion Criteria
- •Patients diagnosed or suspected pediatric myocarditis based on Diagnostic Recommendation for Myocarditis in Children (version 2018).
- •Age between 1 to 18 years old.
Exclusion Criteria
- •Previous history of cardiovascular disease ( e.g. congenital heart disease, cardiomyopathy, rheumatic heart disease, valvular disease ).
- •MRI examination contraindications ;
- •Gadolinium contrast agent contraindications ;
- •CT examination contraindications ;
- •Comparison of iodine content.
Outcomes
Primary Outcomes
Adverse cardiovascular events
Time Frame: 10 years after the onset
including all-cause death, orthotopic heart transplantation(HTx), malignant arrhythmia, readmission due to heart failure, progression to DCM.
Secondary Outcomes
- Secondary cardiovascular adverse events(10 years after the onset)